Advances in cancer research are ushering in precision treatments designed to be more effective and less toxic to the patient. These treatments aim to zero in on a tumor and are less concerned with where it originated, says Stephen Graziano, MD, Upstate’s division chief of hematology and oncology. This could mean, for example, that a patient takes an oral medicine at home, with less nausea and hair loss than in traditional chemotherapy. Graziano cautions, however, that these treatments tend to be for a small percentage of patients and usually for more advanced cases. The high cost of these precision treatments will also need to be addressed, probably by Congress, he said.
Podcast: Play in new window